Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial.

ABSTRACT:

SUBMITTER: Ishola D 

PROVIDER: S-EPMC7613326 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature